Under the policy, blood-based tests may be eligible for coverage if they either are cleared or approved by the US FDA or measure phosphorylated-tau 217.
The firm said its long-term roadmap for the test includes addition of integrated, proprietary front-end automation in the future.
Of the roughly 1 million disputes taken through the law's arbitration process in Q2 2025, around 129,000 were for lab codes, with payments for basic tests averaging hundreds of dollars.
British startup Respiro Diagnostics announced on Wednesday that it has raised £1 million ($1.34 million) in a pre-seed funding round to develop a breath-based test for respiratory diseases. The round ...
The test, along with other research-use tests for neurodegenerative disease, run on the Danaher subsidiary's DxI 9000 Immunoassay Analyzer system.
The partnership combines Discovery's clinical laboratory network and biorepository with Biocartis' Idylla PCR-based platform.
Last week, readers were most interested in a rumor about a possible sale of QuidelOrtho's point-of-care business, which sent its stock soaring.
The firm is not in compliance with the minimum bid price requirement for continued listing on the Nasdaq Capital Market.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results